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Kinetic Regulation of Enzymes
Joseph D. Shore, Ph.D.*

This paper, on a highly sophisticated subject written in a non-mathematical
style, provides the reader not only with an understandable review of an important aspect of the metabolic regulation of enzyme activity (i.e.) kinetic
regulation) but also with results of original investigations being conducted in this
specific area of research by Dr. Shore in the Department of Biochemistry and
Molecular Biology of the Ed.sel B. Ford Institute for Medical Research.

Introduction
Regulation of the enzymes involved in metabolism is essential to biochemical
homeostasis in living organisms. Through this regulation, a delicate balance is maintained
in which all enzyme activities are held at a level which prevents accumulation of unnecessary intermediates. It also enables the pathways of carbohydrate, fat and protein
metabolism to proceed simultaneously without one pathway inhibiting others by the
depletion of common intermediates.
There are two general means by which living organisms can control the level of
enzyme activity. The first method, which we shall call genetic regulation, is a relatively
slow process requiring days or weeks for modification of enzyme activities. In this
type of regulation, the rate of synthesis of enzyme is modified by factors acting at
various steps in protein synthesis, or on the segment of the DNA strand involved in
the production of a specific enzyme. Although this subject is one of the more fascinating
areas of molecular biology, the limitations of space prevent discussion of it in this review.
The second type of regulation, to be reviewed here, is the kinetic regulation of
enzymes. This consists of instantaneous modification of the catalytic efficiencies of
enzymes and it provides control of metabolism when the concentrations of metabolite
substrates are constantly varying. Through the use of this type of regulation, the build-up
of potentially toxic products, and wasteful overproduction by biosynthetic pathways,
is prevented. The two major classifications of kinetic regulation to be discussed here
are; product inhibition and allosteric regulation.
*From the Department of Biochemistry and Molecular Biology, The Edsel B. Ford Institute for
Medical Research.
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Product inhibition refers to the inhibition of a reaction as its products accumulate.
There are two general types; equilibrium and competitive. These can perhaps best
be differentiated by considering the following simplified reaction scheme;

S + E = ^ ES

EP T

^E + P

In this scheme, substrate (S) combines with enzyme (E) to form a binary enzymesubstrate complex, which then interconverts to an enzyme-product complex, which
dissociates to enzyme plus product (P).
Equilibrium product inhibition would refer to a situation in which the accumulation
of P would force the equilibrium backward to some extent, decreasing the effective
rate of conversion of S to P. I f the concentration of S were very much greater than P,
this effect would tend to be negligible. In many metabolic pathways, however, the
substrates are present in relatively low concentrations, since they have been produced
by the preceding step of the pathway. Therefore, the reversal of many reactions is a
significant factor and serves to prevent accumulation of intermediates.
Catalytic Nature
In order to understand competitive product inhibition, it is necessary to keep in
mind the catalytic nature of enzymes. E is present in very low concentrations relative
to S and must constantly shuttle back and forth as the reaction proceeds. Any substance
which can bind to the active center of the enzyme, and thus prevent substrate from
binding, would act as a competitive inhibitor (i.e., it would compete with substrate for
the active center). In many enzyme-catalyzed reactions, the product is structurally
very similar to the substrate. This is particularly true in oxidation-reduction reactions,
since the difference between product and substrate is usually one or two electrons and
possibly one or two hydrogen atoms. Thus, the product is able to compete for the substrate binding site and remove free enzyme molecules from the reaction sequence. I f the
product is bound to enzyme much more tightly than the substrate, this inhibitory effect
is likely to be quite pronounced.
A n example of both types of product inhibition can be seen in studies done with
hver alcohol dehydrogenase ( L A D H ) , which catalyzes the following reaction*;

a l c o h o l + NAD"^ T - ^ aldehytde + NADH
The reaction mechanism is an ordered sequence, and can be expressed as a three-step
reaction, using R for N A D H and O for N A D + ;

(1)

E + 0 ;?=±E0

(2)

EO + a l e

(3)

ER

X ^=±ER + aid

E +R

*The following abbreviations are used: NAD-1- = oxidized diphosphopyridine nucleotide (DPN-1-),
NADH = reduced diphosphopyridine nucleotide (DPNH).
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In the presence of aldehyde, one of the products, step (2) is inhibited by a shift
in the equilibrium of that step. This results in an inhibition of the overall reaction rate
since the dissociation of X, the ternary complex, is prevented. Under maximum velocity
conditions, i.e., at saturating levels of both substrates, the inhibition will still be apparent since the dissociation of X to ER and aldehyde is prevented.
L A D H also exhibits competitive product inhibition, in which R can react with
free enzyme to prevent it from binding O. A double reciprocal plot of velocity and
N A D + concentration (Figure 1) demonstrates the kinetics of this effect. It can be
seen that at extrapolated infinite concentrations of NAD+ there is no change in velocity.
This is indicative of a competition between N A D + and N A D H for the same site on
the enzyme. N A D H is a particularly effective inhibitor since the dissociation constant

V

IQ3

CNAD+]
Figure 1
The effect of NADH on the oxidation ot ethanol by NAD-|-.. Liver alcohol dehydrogenase concentration, 5 X 10-8 M, Ethanol concentration, 6.4 mM. The experiments were performed in pH 7.0
phosphate buffer, pH 7.0, at 23.5° C. • control; ^ , 3.3 ^iM, NADH; O, 6.6 ^ M NADH.
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of the ER complex is 0.3 while the value for the EO complex is 160.' Therefore,
the product is much more tightly bound than substrate, and is able to regulate the
enzyme effectively.
Both types of product inhibition of LADH have physiological significance. The
inhibition by acetaldehyde will prevent further accumulation of this product from the
ethanol substrate. Acetaldehyde would then be metabolized to acetyl-CoA, which is an
intermediate in lipid synthesis, and the toxic effects of accumulation of fat in the liver
would be damped. The inhibition by N A D H provides a link between the metabolism
of ethanol and the many other metabolic processes resulting in N A D H production.
Thus, the intracellular level of N A D H will regulate L A D H and prevent the metabolism
of ethanol at a faster rate than the body can accommodate.
There are many other well documented examples of product inhibition.^ Perhaps the best known is the control of blood glucose level by the product inhibition
of liver glucose-6-phosphatase. In this case, the enzyme is always subject to inhibition
by glucose, and as the blood glucose level rises, the production of glucose from glucose6-phosphate is diminished. During starvation, when the blood glucose level falls, the
enzyme is released from product inhibition and the production of glucose is enhanced.
In this way, product inhibition plays a significant role in maintaining a constant blood
sugar level despite dietary extremes.
Allosteric Effects
The general concept of allosteric regulation describes a situation in which a modifier, which can either activate or inhibit the enzyme, binds to the enzyme and changes
its kinetic properties. The modifier is usually not related to the reaction, and exerts
its effect by combining with the allosteric site and causing a change in the conformation
of the enzyme. In its newer conformation, the affinity of the enzyme for its substrate
is modified. On the other hand, substrate binding also causes a conformational change,
which decreases the affinity of the enzyme for its modifier. At saturating levels of
substrate, no effect of modifier can be determined. This makes it appear as though
allosteric inhibitors are competing directly for the substrate binding sites.
Although the prevalence and significance of product inhibition have been realized
for the past 10 to 15 years, the concept of allosteric effects is much more recent.
Despite isolated reports since 1953^ of inhibition of the biosynthesis of metabolites
by the metabolites themselves, the general applicability of this phenomenon was not
elucidated until 1963 when Monod, Changeux and Jacob" proposed that certain
key enzymes played a well-defined regulatory role in metabolism. According to their
concept, these enzymes possessed two sites, an "allosteric" site which could combine
with a modifier, and an "active" site at which substrates were bound. The term "allosteric" was used to indicate that the modifier was sterically unrelated to the substrate
and therefore not likely to combine at the substrate binding site.
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There are many types of allosteric effects currently known, and undoubtedly many
which have not yet been discovered. The least complicated would be the regulation
of a linear biosynthetic pathway through feedback inhibition. If the pathway is
expressed as ^
»-C
*-E 'he end product, E. can inhibit
the enzyme catalyzing the ^
reaction. Thus, as E accumulates, the pathway
is stopped at its origin and the intermediates B, C and D are not accumulated. There are
many examples of this type of control: histidine inhibits phosphoribosyl-ATP-pyrophosphorylase,' isoleucine inhibits threonine deaminase,' and CTP inhibits aspartate transcarbamylase.' It should not be inferred that only the first step in biosynthetic pathways
is regulated. Many cases are known in which several steps are regulated.'
There are many other variations to control by allosteric modifiers. With branched
pathways, in which two or more products result from the same series of initial reactions,
several different kinds of feedback control exist. These include; multiple enzymes
catalyzing the A
B reaction, each under the control of a different end product;
concerted inhibition, in which all end products must be present to cause inhibition of
the common first step; and cumulative inhibition, in which each end product can
partially inhibit the first step.
Allosteric effects are not limited to biosynthetic pathways, but are ubiquitous in
the intermediary metabolism of living organisms. The irreversible steps of glycolysis,
such as the hexokinase and phosphofructokinase reactions, and the glucose-6-phosphatase and fructose 1,6 diphosphates which provide a by-pass of these irreversible
reactions and enable gluconeogenesis to proceed, are under very tight metabolite control.
It has even been reported' that the intracellular level of free fatty acids can selectively inhibit the critical steps of glycolysis, enabling gluconeogenesis and glycogen
synthesis to proceed at an enhanced rate.
Common intermediates are frequently allosteric modifiers. The intracellular levels
of ATP, AMP, inorganic phosphate, acetyl CoA, N A D H and NADPH and many
cations are all involved in the allosteric regulation of metabolic enzymes.''" It is
not unusual for one of these modifiers to inhibit a reversible reaction in one direction,
and activate the reaction in the reverse direction. This enables a tighter control of
metabolism by these effectors.
Many allosteric enzymes exhibit peculiar kinetic behavior, showing a sigmoid
shaped curve of velocity versus substrate concentration, as contrasted to the hyperbolic
first order curve usually found for enzymes. In the presence of allosteric modifiers,
the curves assume a hyperbolic shape. These effects have led to many theories, two
of which will be mentioned because they are the most popular.
The Monod-Changeux-Wyman model" proposes that allosteric enzymes are polymeric and composed of conformationally different sub-units in equilibrium with each
other in solution. Each sub-unit is able to combine with both substrate and allosteric
223
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effector, with a concurrent shift in the equilibrium between the two forms of the
enzyme. Although this model explained the kinetic behavior of most allosteric enzymes,
it was not the only model which could do this. Other investigators" have proposed two
substrate binding sites, with the binding of substrate to one causing increased substrate
affinity for the other. They proposed that allosteric modifiers could bind to the activating
substrate site, which explained the change to first order kinetics. Thus far, no experimental evidence has been presented which could prove the general validity of any of
the current theories of allosteric effects.
Affording a typical example of allosteric regulation is the reaction catalyzed by
malate dehydrogenase;

malate + NAD"*" i — ^ o x a l o a c e t a t e

+ NADH

It was recently reported'^ that ATP stimulated the reaction from the malate and NAD+
side but inhibited the reverse reaction, the reduction of oxaloacetate by N A D H . Both
the stimulation and inhibition were abolished by pre-treatment of the malate dehydrogenase with dilute mercuric nitrate. This provided an indication of a separate allosteric
site, which was selectively destroyed by the mercuric nitrate treatment.
To gain further insight into this effect, we decided to study the changes in enzyme
conformation and their effect on binding of N A D H . Enzyme conformation was studied
through changes in the fluorescence of the tyrosine and tryptophan residues of the
malate dehydrogenase. When excited at 290 mp, these residues emit light at 325 mp..
This fluorescence emission changes with the change in proportion of exposed residues,
as contrasted to those buried in the internal convolutions of the enzyme molecule.
Figure 2 shows the decrease in malate dehydrogenase fluorescence due to successive
additions of ATP. From this study, it was possible to calculate the dissociation constant
of the malate dehydrogenase-ATP complex, which was 800 /MN.
With an indication that ATP was bound to the enzyme, causing a concomitant
change in its conformation, the next step was to discern the effect of ATP on the
binding of N A D H to the enzyme. I f N A D H is excited at 330 mp. it emits light at
440 m/i. The binding of malate dehydrogenase to the N A D H causes a shift to 432 mp
and enhancement of the fluorescence emission. Figure 3 shows an experiment in which
malate dehydrogenase was added to the enzyme. Following this, successive additions
of ATP were made until no further change in spectrum was seen. At excess ATP, the
spectrum still had not returned to the normal N A D H emission spectrum, indicating
that only a portion of the N A D H was dissociated from the enzyme-NADH complex.
If the ATP was reacting at the N A D H binding site, a complete dissociation would
occur in the presence of excess ATP and the spectrum would return to a pure N A D H
spectrum.
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A Fl

290

340

390

Figure 2
Fluorescence emission spectra of 2.6 /iN malate dehydrogenase, with additions of ATP, in 0.1 ^
phosphate buffer, pH 7.0. The excitation wavelength was 290 m^. The highest peak represents pure
MDH, and the next two peaks were obtained in the presence of 540 and 1080
ATP. The
dashed line was obtained in the presence of excess ATP (10,800 fiN).

AFl

Figure 3
The fluorescence emission of NADH (R), NADH-malate dehydrogenase complex (ER), and
changes caused by ATP. The excitation wavelength was 330 m/x, and the studies were carried out
in 0.1 / i phosphate buffer, pH 7.0 (dotted line, second from top), in the presence of 334 f M ATP;
dash line (third from lop), in ihe presence of excess ATP (3340 /liN).
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The significance of these studies can be visualized schematically in Figure 4.
In this figure, the ordered nature of the reaction mechanism, and the allosteric interaction, are explained on the basis of conformational changes. Ordered nature can be
seen by the pathway which demonstrates that no substrate binding site exists on free
enzyme, but that the binding of R creates a site which can bind substrate. It can also
be seen that modifier can bind free enzyme. This was demonstrated by the addition

ER

+R

Figure 4
Schematic illustration of conformational changes in malate dehydrogenase (E). M, modifier (ATP);
R, coenzyme (NADH); S, substrate (oxaloacetate).
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of ATP to free enzyme causing decreased tyrosine fluorescence. The binding of modifier
results in diminished affinity of enzyme for N A D H ( R ) , which was demonstrated by
the experiment in which ATP was added to enzyme-NADH complex.
Conclusion
The brief, non-mathematical treatment of kinetic regulatory mechanisms presented
in this article is not intended as a basis for research in this field. Several extensive
review articles^-' '" would better serve that purpose. This presentation is only an attempt
to familiarize readers with the general phenomena and concepts, and to provide an
awareness of one of the relatively new areas of biochemical research.
The potential significance of research in enzyme regulation is very great. Diseases
in which cellular metabolism has become modified are at least partially due to a breakdown in regulatory mechanisms. Furthermore, increased understanding of the means by
which enzymes are normally regulated may well provide a basis for the development
of therapeutic agents for the treatment of diseases of metabolic origin.
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